STOCK TITAN

Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch

(Positive)
Tags

Virtuix (NASDAQ: VTIX) reported first quarter fiscal 2027 results for the period ended June 30, 2026. New orders for Omni One systems rose 72% year-over-year and approximately 150% since the launch of Omni One for Quest in collaboration with Meta, with momentum continuing into the current quarter. Net sales declined to $0.8 million from $1.0 million, reflecting completion of the legacy preorder backlog last year and a shift to newly acquired customers.

Gross profit increased 29% to $227,158 and gross margin expanded to 30% from 17%, driven by higher Omni One pricing. Operating expenses rose 86% to $4.1 million and total other expense reached $3.2 million, largely from non-cash interest and financing items, widening net loss to $7.2 million. Cash stood at $7.4 million. The company highlighted defense growth (Marine Corps trainers, Air Force SBIR award, Air National Guard deployment), expansion into enterprise robotics via a first sale to Tesla’s Optimus program, NASA’s Moon and Mars Exploration Analog mission, and a healthcare partnership with Sirica Therapeutics.

Loading...
Loading translation...

Positive

  • Omni One orders +72% YoY and ~150% since Omni One for Quest launch
  • Gross profit up 29% to $227,158; gross margin improved to 30% from 17%
  • Defense pipeline expanded with Marine Corps trainers, Air Force SBIR Phase I, and first Air National Guard deployment
  • Enterprise and robotics expansion with first Omni One Enterprise sale to Tesla’s Optimus humanoid robot division
  • Strategic missions including selection for NASA’s Moon and Mars Exploration Analog starting in 2027
  • Healthcare entry via Sirica Therapeutics partnership, with two systems delivered and plans for ~100 treatment centers

Negative

  • Net sales declined 26% year-over-year to $0.8 million from $1.0 million
  • Net loss widened to $7.2 million from $2.3 million year-over-year
  • Adjusted EBITDA loss increased to $3.1 million from $1.9 million
  • Operating expenses rose 86% to $4.1 million, including $0.7 million higher stock compensation and $1.2 million more professional fees
  • Other expense climbed to $3.2 million, including $2.5 million interest and debt discount amortization plus $0.6 million financing expense
  • Cash balance decreased to $7.4 million at June 30, 2026 from $9.5 million at March 31, 2026

News Explained

The completed quarter shows a larger share base and current notes payable exceeding cash, affecting ownership and disclosed liquidity.

In the completed first-quarter report, Class A shares issued and outstanding rose from $28,562,693 at March 31, 2026 to $28,898,026 at June 30, 2026, although the release does not identify the mechanism.

If that increase reflects additional shares, the supplied dilution definition means existing holders’ percentage ownership is reduced absent offsetting changes.

At June 30, 2026, the current portion of notes payable was $9,658,998 versus $7,443,869 of cash and cash equivalents, so disclosed current notes payable exceeded cash.

Market reaction after 1Q27 earnings report: VTIX +12.06%

+12.06% $1.82
15m delay
+12.06% Vs previous close
+42.5% Peak in 9 min
$1.82 Last Price
$1.54 $1.88 Day Range
$61.56M Market Cap
1.0x Rel. Volume

Following this news, VTIX has gained 12.06%, reflecting a significant positive market reaction. Argus tracked a peak move of +42.5% during the session. Our momentum scanner has triggered 51 alerts so far, indicating high trading interest and price volatility. The stock is currently trading at $1.82.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Insider context recorded Net Selling, with 503985 shares sold and none bought across 90 days. That a...
Analysis

Insider context recorded Net Selling, with 503985 shares sold and none bought across 90 days. That adds insider-selling risk, while low short positioning provides limited evidence of crowded bearish exposure.

Key Figures

Omni One orders growth: 72% year-over-year; approximately 150% since Meta launch Net sales: $0.8 million Gross profit: $227,158 +5 more
8 metrics
Omni One orders growth 72% year-over-year; approximately 150% since Meta launch First quarter fiscal 2027
Net sales $0.8 million Three months ended June 30, 2026, versus $1.0 million prior year
Gross profit $227,158 Three months ended June 30, 2026, versus $176,077 prior year
Gross margin 30% First quarter fiscal 2027, versus 17% prior year
Net loss per share ($0.22) Three months ended June 30, 2026, versus ($0.28) prior year
Operating expenses $4.1 million Three months ended June 30, 2026, versus $2.2 million prior year
Net loss ($7.2) million Three months ended June 30, 2026, versus ($2.3) million prior year
Cash and cash equivalents $7.4 million As of June 30, 2026, versus $9.5 million as of March 31, 2026

Previous Earnings Reports

2 past events · Latest: Jul 02 (Positive)
Same Type Pattern 2 events
Date Event Sentiment 24h Move Catalyst
Jul 02 Analyst rating update Positive -7.4% Rating reiteration cited revenue growth, Meta distribution, defense activity, and projected future expansion.
Mar 05 Quarterly earnings report Positive -8.5% Nine-month sales growth and improving margins accompanied expansion across consumer, enterprise, and defense markets.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Both available earnings-tag events produced negative 24-hour reactions despite positive or growth-oriented disclosures.

Key Terms

gross margin, adjusted ebitda, convertible notes, sbir, +1 more
5 terms
gross margin financial
"Gross margin expanded to 30% from 17% in the prior-year period"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
View in glossary
adjusted ebitda financial
"Adjusted EBITDA loss for the three months ended June 30, 2026"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
convertible notes financial
"related to the Company’s convertible notes"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
sbir regulatory
"Awarded U.S. Air Force funding under Phase I of the AFWERX SBIR program"
SBIR stands for Small Business Innovation Research, a government program that gives grants or contracts to small companies to develop and test new technologies. Think of it as a government-funded pilot customer that pays a startup to prove its idea works, which lowers development cost and risk. For investors, SBIR awards signal third-party validation, provide non-dilutive funding, and can open pathways to larger government contracts or commercial markets.
counter-uas technical
"LeadTech's Counter-UAS Personnel Trainer"
Counter-UAS (counter-unmanned aircraft systems) are tools and tactics used to detect, track, and disable or divert drones that pose a threat to people, property, or operations. Think of them as a combination of a security camera, alarm system, and net that can find an unwanted flying device and stop it before it causes harm. Investors care because demand, regulation, and deployment of these systems affect revenue, contract opportunities, legal risk, and the valuation of companies that build or use them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand

Gross Profit Increased 29%; Gross Margin Expanded to 30% from 17%

Defense Expansion Accelerates with Counter-UAS Trainer and Infantry Fireteam Trainer for U.S. Marine Corps, SBIR Phase I Award from U.S. Air Force, and First Deployment to Air National Guard

Omni One Enterprise Expands to Tesla for Humanoid Robot Teleoperation, NASA for Moon and Mars Exploration Analog Mission, and Sirica Therapeutics for AI-Driven Healthcare

Management to Host Conference Call Tomorrow at 8:30 a.m. Eastern Time

AUSTIN, Texas, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX) (the “Company”), a leading developer of AI-driven, full-body simulation systems, today reported financial and operational results for the first quarter of fiscal year 2027 ended June 30, 2026.

Key First Quarter Fiscal 2027 Results and Subsequent Highlights

  • New orders for Omni One systems in the quarter increased 72% year-over-year and approximately 150% since the launch of Omni One for Quest compared to the same period last year, with similar momentum continuing into the current quarter.
  • Net sales were $0.8 million compared to $1.0 million in the prior-year period, which benefited from fulfilment of the final batch of legacy backlog accumulated since 2023. Current-quarter revenue was generated from newly acquired customers.
  • Gross profit increased 29% and gross margin expanded to 30% from 17% in the prior-year period, reflecting higher Omni One system pricing.
  • Net loss per share narrowed from ($0.28) to ($0.22) per share.
  • Advanced its U.S. Marine Corps Infantry Fireteam Trainer as lead systems integrator with the selection of AVRT to provide weapons tracking and immersive training content. Delivery of the pilot system to the U.S. Marine Corps in Quantico, VA, is expected in the fourth calendar quarter of 2026.
  • Entered the counter-drone training market through integration with LeadTech's Counter-UAS Personnel Trainer for evaluation by the U.S. Marine Corps.
  • Awarded U.S. Air Force funding under Phase I of the AFWERX SBIR program to advance development of its Virtual Terrain Walk (“VTW”) platform for military mission planning and leader rehearsals.
  • Delivered an Omni One system to the Pennsylvania Air National Guard for use of AI-driven virtual reality military training, marking the Company's first deployment with the Air National Guard.
  • Sold its first Omni One Enterprise system to Tesla, Inc. for the company’s Optimus humanoid robot division, where the system is being used for teleoperation, enabling an operator to remotely control a humanoid robot in real time.
  • Won the Company’s second consecutive 2026 Auggie Award for Best Interaction Product at Augmented World Expo, recognizing Omni One as part of a humanoid robot teleoperation system developed with the University of Central Florida’s Institute for Simulation & Training.
  • Selected for NASA's Moon and Mars Exploration Analog (MMEA) mission, with Omni One supporting simulated extravehicular activities during a year-long study beginning in 2027.
  • Partnered with Sirica Therapeutics to advance AI-driven autism therapy, delivering two Omni One systems to its treatment center. Sirica plans to establish approximately 100 treatment centers nationwide.

Management Commentary

“The first quarter of fiscal 2027 was one of the strongest commercial quarters in our Company’s recent history,” said Jan Goetgeluk, CEO of Virtuix. “New orders for Omni One systems increased 72% year-over-year, and have increased approximately 150% since the launch of Omni One for Quest in collaboration with Meta, a trend we have seen continue into the current quarter.

“While reported revenue was lower year-over-year, that comparison reflects the completion of our legacy preorder backlog: revenue in the prior-year period was driven largely by the fulfillment of the final batch of the large backlog of Omni One orders accumulated since the start of our preorder period in August 2023, whereas revenues this quarter resulted from sales to newly acquired customers. We believe new orders are the better forward indicator of the accelerating demand we are currently seeing.

“Our unit economics also continued to improve. Gross profit increased 29% year-over-year and gross margin expanded to 30% from 17%, primarily reflecting the higher selling price of the complete Omni One system in the first quarter of fiscal 2027 compared to the price of units delivered in the prior-year period. We ended the quarter with $7.4 million of cash.

"The launch of the Made for Meta certified Omni One for Quest has expanded our addressable market to millions of active Quest users and is already reshaping our order profile. We believe it represents an important step toward our goal of driving continued consumer sales growth and bringing our immersive, physically engaging entertainment experience to millions of households nationwide. We believe we are only scratching the surface of the potential of our Meta partnership, as we are exploring joint marketing opportunities and the bundling of Virtuix and Meta products.

“Our defense business continues to gain momentum. As lead systems integrator, we’re advancing the development of the U.S. Marine Corps Infantry Fireteam Trainer, while also expanding into the counter-drone training market through LeadTech's C-UAS Personnel Trainer, and we completed our first deployment with the Air National Guard.

“We are also pursuing inorganic growth in the defense sector. Our special committee is actively reviewing acquisition opportunities in the defense training and simulation industry, with a focus on companies with annual revenues in the $10 million to $50 million range that would provide immediate access to government contract vehicles and recurring defense revenues.

"Beyond defense, we expanded into enterprise robotics through our first sale to Tesla's Optimus program, were selected for NASA's moon and mars mission, and earned our second consecutive Auggie Award, demonstrating the expanding commercial potential of Omni One."

“In healthcare, we signed a strategic partnership with Sirica Therapeutics and shipped two Omni One systems to Sirica’s San Francisco Bay Area treatment center to advance AI-driven autism therapy. Sirica announced plans to establish approximately 100 treatment centers nationwide, and we believe full-body movement within AI-enabled environments may play an increasingly important role across next-generation healthcare and therapeutic applications.

“Looking ahead, we are focused on converting the order momentum we are seeing in our consumer business into accelerating revenue growth, advancing our defense programs toward larger awards, completing one or more acquisitions in the defense space, and expanding into enterprise robotics and healthcare applications. Through our multi-use platform strategy, we intend to complement high-volume consumer sales with high-value defense and enterprise contracts, including recurring revenues from software licensing and customized simulation development. We look forward to additional updates in the coming months as we seek to bring long-term value to our stockholders,” concluded Goetgeluk.

First Quarter Financial Results

Net sales for the three months ended June 30, 2026 were $0.8 million, a 26% decrease compared to $1.0 million for the prior year period. The overall higher revenue in the three months ended June 30, 2025 was primarily attributable to the fulfillment of the final batch of the large backlog of Omni One orders accumulated since the start of the preorder period in August 2023, whereas revenues in the first quarter of fiscal 2027 resulted from sales to newly acquired customers. New orders for Omni One systems increased 72% in the three months ended June 30, 2026 compared to the same period last year.

Gross profit in the three months ended June 30, 2026 increased 29% to $227,158, compared to $176,077 in the prior year period. Gross margin as a percentage of revenues expanded to 30% in the three months ended June 30, 2026, from 17% in the prior year period. The improvement was primarily the result of the higher selling price of the complete Omni One system in the first quarter of fiscal 2027 compared to the price of units delivered in the prior-year period.

Total operating expenses increased by $1.9 million, or 86%, to $4.1 million in the three months ended June 30, 2026, compared to $2.2 million in the prior year period. The increase was primarily due to a non-cash $0.7 million increase in stock compensation expense and a $1.2 million increase in professional services fees related to operating as a publicly traded company, including legal, accounting, investor relations, and other professional services.

Total other expense was $3.2 million in the three months ended June 30, 2026, compared to $0.2 million in the prior year period. The increase was primarily attributable to non-cash expenses, including $2.5 million of interest expense and non-cash amortization of debt discount related to the Company’s convertible notes.

Net loss for the three months ended June 30, 2026 was ($7.2) million compared to ($2.3) million for the three months ended June 30, 2025. The increase in net loss primarily reflects $4.0 million of non-cash charges and higher operating expenses, partially offset by the improvement in gross profit.

Adjusted EBITDA loss for the three months ended June 30, 2026 was ($3.1) million, compared to a loss of ($1.9) million for the three months ended June 30, 2025.

Net loss per basic and diluted share for the three months ended June 30, 2026 was ($0.22), compared to ($0.28) for the prior year period.

Cash and cash equivalents totaled $7.4 million as of June 30, 2026, compared to $9.5 million as of March 31, 2026.

First Quarter Fiscal Year 2027 Financial Results Conference Call

Virtuix Founder, Chief Executive Officer, and Chairman Jan Goetgeluk and Chief Financial Officer Thomas McGinnis will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed following the call via the investor relations section of the Company’s website here.

To access the call, please use the following information:
Date: Thursday, August 20, 2026
Time: 8:30 a.m. Eastern time
U.S. dial-in: 1-877-425-9470
International dial-in: 1-201-389-0878
Conference ID: 13761831
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1770243&tp_key=19ebd0fc8f

A telephone replay will be available approximately three hours after the call and will run through Thursday, September 3. To listen, please dial 1-844-512-2921 (U.S.) or 1-412-317-6671 (international) and use replay PIN 13761831. A webcast replay will also be available on the Company’s investor relations website.

Note About Non-GAAP Financial Measures

Adjusted EBITDA is a non-GAAP financial measure. The Company defines Adjusted EBITDA as net loss adjusted to exclude: (i) provision for (benefit from) income taxes, (ii) interest expense, net, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) financing expense, (vi) loss on extinguishment of debt, and (vii) gains or losses from changes in the fair value of financial instruments. Adjusted EBITDA is not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”) and should not be considered in isolation or as a substitute for net loss or any other measure of performance calculated in accordance with GAAP. The Company believes Adjusted EBITDA provides useful supplemental information to investors regarding the performance of its ongoing operations, and management uses it to evaluate operating performance and allocate resources. Because Adjusted EBITDA is not determined in accordance with GAAP and is susceptible to varying calculations, it may not be comparable to similarly titled measures presented by other companies. A reconciliation of net loss, the most directly comparable GAAP measure, to Adjusted EBITDA is presented below.

  For the Three Months Ended
June 30,
 
  2026  2025 
  (Unaudited) 
Reconciliation of GAAP net loss to Adjusted EBITDA   
NET LOSS $(7,170,566) $(2,307,155)
Plus:        
Taxes  49,391   23,418 
Interest expense, net(1)  2,539,429   119,114 
Depreciation and amortization  142,953   158,776 
EBITDA $(4,438,793) $(2,005,847)
Plus:        
Stock-based compensation(2)  722,937   10,897 
Financing expense(3)  584,150   0 
Loss on extinguishment of debt  431,224   122,864 
Less:        
Change in fair value of financial instruments  (372,350)  0 
ADJUSTED EBITDA $(3,072,832) $(1,872,086)
 

(1) Interest expense for the three months ended June 30, 2026 includes $2,052,255 of non-cash amortization of debt discount related to the Company’s financing arrangements. The debt discount results from the issuance of warrants, original issue discounts, related closing costs, and embedded derivative bifurcation, which are being amortized to interest expense over the term of the notes.
(2) Stock-based compensation expense for the three months ended June 30, 2026 consisted of non-cash expenses of $103,080 related to equity awards granted to vendors and service providers and $619,857 related to equity awards granted to employees, officers, and directors. Stock-based compensation expense for the three months ended June 30, 2025 consisted entirely of employee, officer, and director awards.
(3) Financing expense represents a non-cash charge recognized in connection with amendments to certain outstanding warrants during the three months ended June 30, 2026.

About Virtuix

Virtuix Holdings Inc. (NASDAQ: VTIX) is a leading manufacturer of AI-driven, full-body simulation systems for consumer, enterprise, healthcare, and defense markets. The company’s premier portfolio of “Omni” omni-directional treadmills enables players to walk and run in 360 degrees without boundaries inside AI-generated worlds. With a focus on immersive entertainment, defense training, and enterprise applications, Virtuix continues to push the boundaries of full-body XR and AI-driven immersive experiences for users worldwide. For more information, visit virtuix.com.

Please visit the Company’s new Investor Relations website at invest.virtuix.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “would,” “potential,” “continue,” “focused,” “looking ahead,” “plans to,” “seek to,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding: the Company’s expectation that recent new order growth will continue and will convert into future revenue growth, including statements about accelerating consumer demand and similar momentum continuing into the current quarter; the Company’s plans to pursue strategic acquisitions in the defense training and simulation industry, including its focus on companies with annual revenues in the $10 million to $50 million range and the potential benefits, synergies, and impact on revenues or shareholder value of any such acquisition; the Company’s position in the defense training market and plans to advance its defense programs toward larger awards; the anticipated timing and scope of the U.S. Marine Corps Infantry Fireteam Trainer program, including expected delivery of the pilot system to Quantico, VA in the fourth calendar quarter of 2026; the outcome of counter-drone and other military evaluations, including the LeadTech Counter-UAS Personnel Trainer for evaluation by the U.S. Marine Corps; expectations regarding government contract opportunities, including AFWERX SBIR Phase I funding and potential Phase II and Phase III funding; expectations regarding the Meta collaboration and the Omni One for Quest launch, including potential joint marketing opportunities and bundling of Virtuix and Meta products, and the Company’s goal of driving continued consumer sales growth and bringing its experience to millions of households nationwide; expectations regarding enterprise and robotics applications, including the Company’s relationship with Tesla’s Optimus humanoid robot program; expectations regarding the NASA Moon and Mars Exploration Analog mission, including simulated extravehicular activities during a year-long study beginning in 2027; expectations regarding therapeutic and healthcare applications, including the Sirica Therapeutics partnership and Sirica’s plans to establish approximately 100 treatment centers nationwide; statements regarding future gross margin improvement and unit economics; statements regarding the Company’s multi-use platform strategy, including complementing high-volume consumer sales with high-value defense and enterprise contracts and recurring revenues from software licensing and customized simulation development; and statements regarding future market growth, demand, and bringing long-term value to stockholders. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to: the Company’s ability to convert new orders into revenue; the Company’s need for additional capital and its ability to obtain financing on acceptable terms or at all; the Company’s limited cash runway and the substantial doubt regarding the Company’s ability to continue as a going concern, as disclosed in the Company’s latest Quarterly Report on Form 10-Q; the Company’s ability to meet its convertible note and other debt obligations when due; risks related to the Company’s outstanding indebtedness; the Company’s ability to identify, negotiate, and complete acquisitions on favorable terms or at all; the ability to successfully integrate any acquired business; the ability to achieve anticipated synergies, revenues, or shareholder value from any acquisition; risks related to government contracting, including contract cancellations, modifications, or funding changes; uncertainties regarding the timing and success of defense program milestones, evaluations, and deployments; the uncertainties related to market conditions, including consumer demand for virtual reality products; the Company’s ability to maintain its collaboration with Meta and achieve anticipated benefits therefrom; risks related to partnerships and collaborations with third parties, including Tesla, NASA, Sirica Therapeutics, and other enterprise customers; risks related to international expansion; competition in the virtual reality, defense training, and simulation markets; and other factors discussed in the “Risk Factors” section of the Company’s filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof, except as required by law.

Visit Us on Social Media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

Company Contact
Lauren Premo
Virtuix Holdings Inc.
press@virtuix.com

Investor Relations Contact
Chris Tyson
MZ Group
Direct: 949-491-8235
VTIX@mzgroup.us

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
JUNE 30, 2026 (UNAUDITED) AND MARCH 31, 2026
 
ASSETS
 
     March 31, 
  June 30,
2026
  2026
(As Revised)
 
CURRENT ASSETS      
Cash and cash equivalents $7,443,869  $9,471,288 
Receivables, net of allowance for credit losses  465,403   379,289 
Inventory  1,373,385   1,188,623 
Prepaids and other current assets  764,516   897,109 
TOTAL CURRENT ASSETS  10,047,173   11,936,309 
         
NONCURRENT ASSETS        
Property and equipment  1,414,460   1,413,294 
Less: accumulated depreciation  (1,066,258)  (1,034,984)
Net property and equipment  348,202   378,310 
         
Intangibles  2,802,690   2,797,741 
Less: accumulated amortization  (1,370,066)  (1,258,387)
Net intangibles  1,432,624   1,539,354 
         
Investment in joint venture  -   40,619 
         
Other assets  50,975   87,264 
         
Right-of-use asset - operating  701,512   779,514 
TOTAL NONCURRENT ASSETS  2,533,313   2,825,061 
         
TOTAL ASSETS $12,580,486  $14,761,370 
 


LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
 
     March 31, 
  June 30,
2026
  2026
(As Revised)
 
CURRENT LIABILITIES      
Accounts payable $662,290  $721,792 
Accrued expenses  588,772   559,517 
Deferred revenue  639,551   666,327 
Gift card liability  445,744   446,252 
Current portion of notes payable, net of discount and unamortized deferred loan costs  9,658,998   5,328,477 
Derivative liabilities at fair value  1,900,649   2,709,817 
Current portion of EIDL loan  576   570 
Lease liability - operating  256,966   286,702 
TOTAL CURRENT LIABILITIES  14,153,546   10,719,454 
         
LONG-TERM LIABILITIES        
Notes payable, net of discount and unamortized deferred loan costs  1,039,518   2,428,835 
EIDL loan  23,371   23,517 
Lease liability, net of current portion - operating  444,546   492,812 
TOTAL LONG-TERM LIABILITIES  1,507,435   2,945,164 
         
TOTAL LIABILITIES  15,660,981   13,664,618 
         
STOCKHOLDERS’ (DEFICIT) EQUITY        
         
Class A common stock, $.001 par value, 300,000,000 shares authorized at June 30, 2026 and March 31, 2026 and 28,898,026 and 28,562,693 shares issued and outstanding at June 30, 2026 and March 31, 2026, respectively  28,897   28,562 
Class B common stock, $.001 par value, 50,000,000 shares authorized at June 30, 2026 and March 31, 2026 and 4,000,000 shares issued and outstanding at June 30, 2026 and March 31, 2026  4,000   4,000 
Additional paid-in capital  83,403,609   80,410,625 
Accumulated deficit  (86,517,001)  (79,346,435)
TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY  (3,080,495)  1,096,752 
         
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY $12,580,486  $14,761,370 
 


VIRTUIX HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED JUNE 30, 2026 AND 2025 (UNAUDITED)
 
  Three Months Ended
June 30,
 
  2026  2025 
       
SALES $767,300   1,032,136 
         
COST OF GOODS SOLD  540,142   856,059 
         
GROSS PROFIT  227,158   176,077 
         
OPERATING EXPENSES        
Selling expenses  738,978   1,049,658 
General and administrative expenses  3,080,778   959,392 
Research and development expenses  309,375   208,716 
         
TOTAL OPERATING EXPENSES  4,129,131   2,217,766 
         
LOSS FROM OPERATIONS  (3,901,973)  (2,041,689)
         
OTHER INCOME (EXPENSE)        
Loss on disposal of assets  (5,132)  - 
Interest income  163   185 
Other income  9,002   - 
Loss on extinguishment of debt  (431,224)  (122,864)
Loss on derecognition of equity method investment  (40,619)  - 
Change in fair value of derivative liabilities  349,128   - 
Change in fair value of debt  23,222   - 
Interest expense  (2,539,592)  (119,299)
Financing expense  (584,150)  - 
         
TOTAL OTHER EXPENSE, NET  (3,219,202)  (241,978)
         
PROVISION FOR INCOME TAX  49,391   23,418 
         
         
         
         
SHARE OF LOSS IN JOINT VENTURE  -   (70)
         
NET LOSS $(7,170,566) $(2,307,155)
         
Weighted average common shares outstanding:        
Basic and Diluted  32,787,960   8,259,732 
Net loss per share:        
Basic and Diluted $(0.22) $(0.28)
 


VIRTUIX HOLDINGS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2026 AND 2025 (UNAUDITED)
 
  Three Months Ended
June 30,
 
  2026  2025 
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $(7,170,566) $(2,307,155)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expense  142,953   158,776 
Amortization of discount on notes payable  2,052,255   973 
Amortization of loan costs  270,970   1,125 
Credit loss expense  6,094   36,918 
Lease expense - right of use operating  78,002   68,170 
Stock-based compensation  619,857   10,897 
Change in fair value of derivative liabilities  (349,128)  - 
Change in fair value of debt  (23,222)  - 
Loss on disposal of assets  5,132   - 
Loss on derecognition of the equity method investment  40,619   - 
Share of loss in joint venture  -   70 
Warrant modification expense  584,150   - 
Loss on extinguishment of debt  431,224   122,864 
Stock issuance in exchange for services  103,080   - 
Payments on operating leases  (91,244)  (82,591)
Due from related parties  -   21,345 
(Increase) decrease in assets:        
Prepaid expenses and other current assets  132,593   17,993 
Accounts receivable  (92,208)  (53,222)
Other assets  36,289   810 
Inventory  (184,762)  292,557 
Increase (decrease) in liabilities:        
Accounts payable  (59,502)  351,188 
Accrued expenses  186,627   193,645 
Gift card liability  (508)  - 
Operating lease liabilities  13,242   14,421 
Deferred revenue  (26,776)  (339,906)
CASH USED IN OPERATING ACTIVITIES  (3,294,829)  (1,491,122)
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Cash paid for purchases of property and equipment  (6,298)  (1,304)
Cash paid for purchases of intangibles  (4,949)  (2,192)
CASH USED IN INVESTING ACTIVITIES  (11,247)  (3,496)
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Issuance of preferred stock  -   1,493,873 
Payments on short-term notes payable  (4,603)  (110,992)
Payments on long-term notes payable  (140)  (134)
Proceeds from short-term notes payable  -   217,678 
Warrants exercised  1,380,000   79 
Equity issuance costs  (96,600)  - 
CASH PROVIDED BY FINANCING ACTIVITIES  1,278,657   1,600,504 
         
NET (DECREASE) INCREASE IN CASH  (2,027,419)  105,886 
         
CASH AT BEGINNING OF PERIOD  9,471,288   477,908 
         
CASH AT END OF PERIOD $7,443,869  $583,794 

FAQ

What were Virtuix (NASDAQ: VTIX) first quarter fiscal 2027 financial results?

Virtuix reported Q1 FY2027 net sales of $0.8 million, down from $1.0 million, and a net loss of $7.2 million. According to Virtuix, gross profit rose 29% to $227,158 and gross margin expanded to 30%, while operating expenses and non-cash financing costs increased significantly.

How fast did Omni One orders grow for Virtuix (VTIX) in Q1 2027?

Omni One orders increased 72% year-over-year in Q1 FY2027 and approximately 150% since the Omni One for Quest launch. According to Virtuix, this Meta-related launch has driven accelerating consumer demand, with similar order momentum continuing into the current quarter.

Why did Virtuix (VTIX) revenue decline despite higher Omni One orders in Q1 2027?

Net sales fell to $0.8 million from $1.0 million because prior-year revenue included fulfillment of a large legacy preorder backlog. According to Virtuix, current-quarter revenue came from newly acquired customers, while new order growth is viewed as a better forward demand indicator.

What drove the higher net loss for Virtuix (VTIX) in first quarter fiscal 2027?

Net loss widened to $7.2 million from $2.3 million due to higher expenses. According to Virtuix, operating expenses rose to $4.1 million and other expense to $3.2 million, mainly from non-cash interest, debt discount amortization, stock-based compensation, and financing charges.

How is Virtuix (NASDAQ: VTIX) expanding in defense and government training markets?

Virtuix is advancing its role as lead systems integrator on the U.S. Marine Corps Infantry Fireteam Trainer and entering counter-UAS training. According to Virtuix, it also received an Air Force AFWERX SBIR Phase I award and delivered its first Omni One system to the Pennsylvania Air National Guard.

What new enterprise and robotics partnerships did Virtuix (VTIX) announce with its Q1 2027 results?

Virtuix sold its first Omni One Enterprise system to Tesla’s Optimus humanoid robot division for teleoperation. According to Virtuix, Omni One was also selected for NASA’s Moon and Mars Exploration Analog mission and partnered with Sirica Therapeutics to support AI-driven autism therapy.

What is Virtuix (VTIX) cash position after first quarter fiscal 2027?

Virtuix ended June 30, 2026 with $7.4 million in cash and cash equivalents, down from $9.5 million at March 31, 2026. According to Virtuix, this balance supports continued investment in consumer growth, defense programs, enterprise robotics, and healthcare initiatives.